Ketamine Blogs
Ketamine Infusion Solutions Blogs
Medical Studies on Ketamine Infusions – Ketamine is a drug that is typically used as an anesthetic. It relieves pain and can even cause feelings of relaxation. It has now begun to be used as a fast and effective intravenous treatment for those suffering from depression – even for those who have not responded well to current therapy options.
While many think that the use of ketamine is a new type of therapy, it has actually been used in clinical settings for quite some time now. Read More
FDA Approves Ketamine for Managing Treatment-Resistant Depression
On March 5th, of 2019 The US Food and Drug Administration approved the Janssen Pharmaceuticals Inc.’s esketamine, on Tuesday March 5th, 2019, for treatment-resistant depression (TRD). This stems from a September 2018 United States Study that is one of five submitted to U.S. FDA by Janssen as part of its new drug application for esketamine nasal spray for treatment-resistant depression… Read More…
A Promising Agent for Managing Treatment-Resistant Depression
Over 16 million people suffer from leading causes of disability in the United States of America, unipolar Major Depressive Disorder (MDD). But there is hope because or a promising agent for managing treatment resistant depression. Click read more to find out how Ketamine, through doctor assisted infusion, can be the freedom from depression you’ve been looking for… Read More…
A Systematic Review of the Role of Ketamine in TRD
A must read article about the background, methods, results, and limitations of how ketamine may be considered a valid and intriguing antidepressant option for the treatment of TRD (Treatment Resistant Depression). “Although many psychopharmacological agents are currently available for the treatment of MDD, approximately 10-20% of patients treated with the common antidepressant medications do not achieve complete recovery and meet the criteria of treatment-resistance…” Read More…
Ketamine Like Hallucinogens May Offer New Hope for TRD
Today, intravenous ketamine is increasingly being used off-label to treat TRD and other mood disorders in academic medical centers and standalone clinics around the country. “For those patients who have tried existing treatment options, have gone through many antidepressants that were appropriately dosed and adequate in duration, have tried the talk therapies and even electroconvulsive therapy (ECT), I can see the need and the urgency of wanting… Read More…
